Kinesin inhibitor, Monastrol, Purity ≥98%

Cat. No.: X24-08-YM321

Kinesin inhibitor, Monastrol, Purity ≥98%

Synonym: 329689-23-8; DL-Monastrol; Ethyl 4-(3-hydroxyphenyl)-6-methyl-2-sulfanylidene-3,4-dihydro-1H-pyrimidine-5-carboxylate

  • MDL: MFCD00813077
  • CAS Number: 329689-23-8
  • Compound CID: 2987927
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Monastrol, soluble in DMSO and ethanol and insoluble in water, is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting kinesin. It targets the Eg5.
Molecular Weight
292.4
Molecular Formula
C14H16N2O3S
Targets
Eg5: 14 μM (IC50)
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 54 mg/mL (184.71 mM); Water: insoluble; Ethanol: 54 mg/mL (184.71 mM)
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Monastrol is a cytoskeletal signaling inhibitor that can be used for its ability to disrupt mitotic spindle function and induce cell death in cancer cells.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.